Bipolar Disorder NICE Guidelines

Bipolar Disorder NICE Guidelines: This guideline from NICE (National Institute for Health and Care Excellence) addresses the recognition, assessment, and treatment of bipolar disorder.

Bipolar Disorder NICE Guidelines:

Bipolar Disorder NICE Guidelines: This guideline from NICE (National Institute for Health and Care Excellence) addresses the recognition, assessment, and treatment of bipolar disorder.

About the Bipolar Disorder NICE Guidelines

The Bipolar Disorder NICE Guidelines from NICE (National Institute for Health and Care Excellence) addresses the recognition, assessment, and treatment of bipolar disorder. This disorder was formerly known as manic depression. The guideline’s recommendations apply to various forms of bipolar disorder, including bipolar I, bipolar II, mixed affective, and rapid cycling disorders. The primary objective of this guideline is to enhance the quality of life for individuals with bipolar disorder and to improve their access to treatment.

MHRA Advice on Valproate:

The guideline has been updated to align with the MHRA (Medicines and Healthcare Products Regulatory Agency) guidance on the use of valproate in women and girls. Specifically, valproate should not be used in women and girls of childbearing potential unless other treatment options are unsuitable and a pregnancy prevention program is in place. There is also mention of temporary advice from the MHRA regarding the valproate pregnancy prevention program during the COVID-19 pandemic.

Safety Advice (August 2023):

In December 2022, the MHRA issued new safety advice concerning the risks associated with valproate for individuals under the age of 55. The guideline will be reviewed once further advice from the MHRA becomes available. It’s emphasized that people currently on valproate should not discontinue its use unless advised by a specialist.

Bipolar Disorder NICE Guidelines Recommendations:

The guideline offers specific recommendations, but the exact details are not provided in the summary.

Bipolar Disorder NICE Guidelines Target Audience:

The guideline is intended for:

  • Healthcare professionals
  • Individuals working in occupational health, social services, and the independent sector
  • Children, young people, and adults diagnosed with bipolar disorder
  • Families and caregivers of those diagnosed with bipolar disorder

Bipolar Disorder NICE Guidelines Development:

This guideline is an update and replaces the NICE guideline CG38 from July 2006. It was previously titled “bipolar disorder: the assessment and Management of bipolar disorder in Adults, children, and young people in primary and secondary care.”

YouTube Videos:

No data was found
Please Note:

All of the content in the DRA section of the site, is copyright protected by DRA World Network Inc., and is not in the public domain.

The DRA Crest logo is Trademark protected by DRA World Network Inc., and is not in the public domain.

Any reprinting or distribution is subject to our Terms of Use and all applicable U.S. and International Copyright and Trademark law.

Bipolar Disorder NICE Guidelines

Play Video
Skip to content